default author photo

Sui Chengjun

Government of the People's Republic of China - Department of Special Treatment and Liver Transplantation

255 Changhai Road

Shanhai, 200438

China

SCHOLARLY PAPERS

1

DOWNLOADS

58

TOTAL CITATIONS

0

Scholarly Papers (1)

Actions:
Email selected abstracts
1.

LncRNA FOXD2-AS1 as a Competitive Endogenous RNA against miR-150-5p Reverses Resistance to Sorafenib in Hepatocellular Carcinoma

Number of pages: 24 Posted: 30 Jan 2019
Yang Cheng, Dong Zhitao, Xu Minhui, Minfeng Zhang, Dai Binghua, Geng Li, Lu Jiongjiong, Sui Chengjun and Jiamei Yang
Government of the People's Republic of China - Department of Special Treatment and Liver Transplantation, Government of the People's Republic of China - Department of Special Treatment and Liver Transplantation, Nanjing Medical University, Government of the People's Republic of China - Department of Hepatic Surgery I (Ward I), Government of the People's Republic of China - Department of Special Treatment and Liver Transplantation, Government of the People's Republic of China - Department of Special Treatment and Liver Transplantation, Government of the People's Republic of China - Department of Special Treatment and Liver Transplantation, Government of the People's Republic of China - Department of Special Treatment and Liver Transplantation and Eastern Hepatobiliary Surgery Hospital, Department of Special Treatment and Liver Transplantation
Downloads 58 (980,173)

Abstract:

Loading...

long non-coding RNA (lncRNA), hepatocellular carcinoma (HCC), sorafenib, resistance, proliferation, pathogenesis